Oragenics, Inc.
1990 Main Street, Suite 750
Sarasota, Florida 34236
September 3, 2024
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549-3628
Attn: Jimmy McNamara
| Re: | Oragenics, Inc. (the “Company”) | |
| Registration Statement on Form S-1 | ||
| File No. 333-281618 | ||
| Request for Acceleration |
Dear Mr. McNamara:
In accordance with Rule 461 of Regulation C promulgated under the Securities Act of 1933, as amended, the undersigned respectfully requests that the effective date of the above referenced Registration Statement on Form S-1 be accelerated so that it will be declared effective at 4:30 p.m., Eastern Time, on September 3, 2024, or as soon thereafter as is practicable.
Once the Registration Statement has been declared effective, please confirm that event with our counsel, Mark Catchur, of Shumaker, Loop & Kendrick, LLP, at (813) 227-2264.
| Very truly yours, | ||
| By: | /s/ Janet Huffman | |
| Name: | Janet Huffman | |
| Title: | Chief Financial Officer | |
cc: Mark A. Catchur, Shumaker, Loop & Kendrick, LLP